US2010112598A1PendingUtilityA1
Novel Assay for Inositol Phosphorylceramide Synthase Activity
Est. expiryMay 22, 2026(expired)· nominal 20-yr term from priority
Inventors:Ake P. Elhammer
G01N 2405/06G01N 2500/02G01N 2405/00C12Q 1/485C12Q 1/34
53
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Disclosed is a simple and reproducible method for assaying inositol phosphorylceramide synthase activity that employs a fluorescence resonance energy transfer pair for measuring enzyme activity. The invention also includes a novel method for identifying IPC synthase inhibitors.
Claims
exact text as granted — not AI-modified1 . A method for measuring inositol phosphorylceramide (IPC) synthase activity comprising:
a) providing a sample containing inositol phosphorylceramide synthase; b) providing a fluorescent labeled IPC synthase substrate; c) providing a phosphate binding compound conjugated to a fluorophor, wherein the phosphate binding compound conjugated to a fluorophor forms a fluorescence resonance energy transfer (FRET) pair with the fluorescent labeled IPC synthase substrate; and d) measuring fluorescence.
2 . The method of claim 1 , wherein the fluorescent labeled IPC synthase substrate is a fluorescent labeled ceramide.
3 . The method of claim 1 , wherein the phosphate binding compound comprises a peptide that includes at least one positively charged amino acid.
4 . The method of claim 1 , wherein the phosphate binding compound comprises a peptide that includes one or more of arginine, histidine and lysine.
5 . The method of claim 3 , wherein the phosphate binding compound comprises a hexapeptide.
6 . The method of claim 2 , wherein the fluorescent labeled ceramide is selected from the group consisting of C5-NBD-ceramide, C6-NBD-ceramide, C12-NBD-ceramide, BODIPY-FL-C5-ceramide, BODIPY-FL-C6-ceramide and BODIPY-TR-C6-ceramide.
7 . The method of claim 2 wherein the fluorescent labeled ceramide is C6-NBD-ceramide.
8 . The method of claim 1 wherein the fluorophor conjugated to the phosphate binding compound is selected from the group consisting of Alexa Fluor 350, anilinonapthalene, dansyl, dapoxyl, dibromobimane, diethylaminocoumarin, dimethylaminocoumarin, dimethylaminonapthalene, monobromobimane, monochlorobimane, napthanlene, pyrene, stilbene and D-346.
9 . The method of claim 1 wherein the fluorophor conjugated to the phosphate binding compound is D-346.
10 . The method of claim 1 wherein the fluorescent labeled substrate is C6-NBD-ceramide and the fluorophor conjugated to the phosphate binding compound is D-346.
11 . The method of claim 1 wherein the sample containing inositol phosphorylceramide synthase is derived from fungal cells.
12 . A method for identifying inositol phosphorylceramide synthase inhibitors comprising
a) providing a sample containing inositol phosphorylceramide synthase; b) providing a test compound to the sample; c) providing a fluorescent labeled IPC synthase substrate; d) providing a phosphate binding compound conjugated to a fluorophor, wherein the phosphate binding compound conjugated to a fluororphor forms a fluorescence resonance energy transfer (FRET) pair with the fluorescent labeled IPC synthase substrate; and e) measuring fluorescence.
13 . A kit comprising
a) a fluorescent labeled IPC synthase substrate and b) a phosphate binding compound conjugated to a fluorophor, wherein the phosphate binding compound conjugated to a fluororphor forms a fluorescence resonance energy transfer (FRET) pair with the fluorescent labeled IPC synthase substrate.
14 . The kit of claim 13 further comprising a sample containing inositol phosphorylceramide synthase.
15 . The kit of claim 13 further comprising phosphatidyl inositol.
16 . The kit of claim 14 further comprising a known modulator of IPC synthase.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.